Walleye Capital LLC Cti Biopharma Corp Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$4.2 - $6.01 $1.61 Million - $2.3 Million	382,967 Added 198.25%	576,137 $2.42 Million
Q4 2022 Feb 14, 2023	SELL	$4.45 - $6.17 $906,918 - $1.26 Million	-203,802 Reduced 51.34%	193,170 $1.16 Million
Q3 2022 Nov 14, 2022	BUY	$5.36 - $7.43 $2.13 Million - $2.95 Million	396,972 New	396,972 $2.31 Million
Q2 2022 Aug 08, 2022	SELL	$3.55 - $6.27 $108,271 - $191,228	-30,499 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.9 - $5.23 $57,948 - $159,509	30,499 New	30,499 $142,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.